X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5684) 5684
Publication (366) 366
Book Chapter (47) 47
Book Review (27) 27
Web Resource (14) 14
Dissertation (9) 9
Magazine Article (5) 5
Conference Proceeding (4) 4
Book / eBook (3) 3
Newspaper Article (3) 3
Journal / eJournal (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (4098) 4098
humans (4078) 4078
obstetrics & gynecology (2912) 2912
pregnancy (2608) 2608
adult (2527) 2527
reproductive biology (1996) 1996
ovarian hyperstimulation syndrome (1977) 1977
index medicus (1797) 1797
in-vitro fertilization (1405) 1405
controlled ovarian hyperstimulation (1130) 1130
fertilization in vitro (1121) 1121
ovulation induction (954) 954
ovulation induction - methods (880) 880
ivf (850) 850
pregnancy rate (843) 843
women (823) 823
invitro fertilization (671) 671
embryo transfer (668) 668
obstetrics and gynecology (663) 663
ovarian hyperstimulation syndrome - prevention & control (636) 636
retrospective studies (635) 635
in vitro fertilization (631) 631
estradiol - blood (602) 602
ovarian hyperstimulation (591) 591
ovulation induction - adverse effects (586) 586
ovarian hyperstimulation syndrome - etiology (574) 574
treatment outcome (552) 552
hyperstimulation (540) 540
male (531) 531
endocrinology & metabolism (504) 504
infertility (504) 504
follicle-stimulating-hormone (497) 497
pregnancy outcome (471) 471
infertility, female - therapy (469) 469
human chorionic-gonadotropin (466) 466
prospective studies (465) 465
fertilization in vitro - methods (464) 464
gonadotropin-releasing hormone - agonists (449) 449
risk factors (441) 441
stimulation (438) 438
gonadotropin-releasing hormone - antagonists & inhibitors (435) 435
ovarian stimulation (421) 421
internal medicine (397) 397
gnrh antagonist (366) 366
ohss (362) 362
ovarian hyperstimulation syndrome - complications (348) 348
cycles (347) 347
luteinizing-hormone (342) 342
prevention (331) 331
estradiol (328) 328
chorionic gonadotropin - administration & dosage (326) 326
endothelial growth-factor (326) 326
gnrh agonist (317) 317
hyperstimulation syndrome (316) 316
gonadotropin (314) 314
animals (302) 302
intrauterine insemination (302) 302
medicine & public health (295) 295
assisted reproduction (292) 292
gynecology (280) 280
ovarian hyperstimulation syndrome - physiopathology (271) 271
gonadotropin-releasing hormone - analogs & derivatives (270) 270
risk (264) 264
fertilization (256) 256
time factors (255) 255
follicle stimulating hormone - blood (254) 254
ultrasonography (253) 253
ovulation (251) 251
ovarian hyperstimulation syndrome - diagnosis (250) 250
assisted reproductive technology (247) 247
human menopausal gonadotropin (247) 247
ovarian hyperstimulation syndrome - epidemiology (244) 244
cryopreservation (239) 239
medicine, general & internal (236) 236
young adult (235) 235
ovarian hyperstimulation syndrome - chemically induced (234) 234
progesterone - blood (233) 233
sperm injections, intracytoplasmic (233) 233
human genetics (232) 232
analysis (231) 231
ovarian hyperstimulation syndrome - therapy (231) 231
gonadotropins (230) 230
developmental biology (228) 228
infertility - therapy (228) 228
luteinizing hormone - blood (228) 228
expression (227) 227
chorionic gonadotropin - therapeutic use (223) 223
progesterone (222) 222
hormones (221) 221
genetics & heredity (219) 219
ovary - drug effects (217) 217
embryo-transfer (216) 216
fertilization in vitro - adverse effects (216) 216
oocytes (214) 214
live birth (209) 209
intracytoplasmic sperm injection (208) 208
ovarian hyperstimulation syndrome - blood (207) 207
pregnancy rates (207) 207
implantation (206) 206
polycystic ovary syndrome (206) 206
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5143) 5143
French (193) 193
German (70) 70
Spanish (67) 67
Korean (62) 62
Chinese (47) 47
Czech (26) 26
Japanese (25) 25
Portuguese (17) 17
Turkish (15) 15
Russian (14) 14
Polish (13) 13
Italian (11) 11
Bulgarian (10) 10
Hungarian (10) 10
Hebrew (8) 8
Danish (6) 6
Dutch (6) 6
Croatian (5) 5
Swedish (5) 5
Persian (4) 4
Serbian (4) 4
Finnish (3) 3
Romanian (2) 2
Slovak (2) 2
Belarusian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta Paediatrica, ISSN 0803-5253, 07/2019
The primary formation of the eye in the human embryo takes place between weeks three and 10, when the eye expresses oestradiol and progesterone receptors in... 
OVARIAN HYPERSTIMULATION
Journal Article
2006, ISBN 9780521857987, 253
Ovarian Hyperstimulation Syndrome (OHSS) is a condition that can occur in women undergoing in vitro fertilization, after having follicle stimulation hormone... 
Ovarian Hyperstimulation Syndrome | Human reproductive technology | Ovaries
Book
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2013, Volume 100, Issue 2, pp. 420 - 429.e7
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 216, Issue 1, pp. 42.e1 - 42.e10
Background Ovarian hyperstimulation syndrome is an iatrogenic complication of controlled ovarian stimulation. Early ovarian hyperstimulation syndrome occurs... 
Obstetrics and Gynecology | letrozole | ovarian hyperstimulation syndrome | aspirin | in vitro fertilization | vascular endothelial growth factor | LUTEAL-PHASE | PERMEABILITY | PREVENTION | SUPPRESSION | ovarian hyperstimulation | OBSTETRICS & GYNECOLOGY | OOCYTE RETRIEVAL | LOW-DOSE ASPIRIN | SYNDROME OHSS | syndrome | in vitro fertilization | IN-VITRO FERTILIZATION | ENDOTHELIAL GROWTH-FACTOR | Severity of Illness Index | Estradiol - metabolism | Ascites - etiology | Primary Prevention | Risk Assessment | Ovarian Hyperstimulation Syndrome - complications | Humans | Ovarian Hyperstimulation Syndrome - diagnostic imaging | Ascites - diagnostic imaging | Ovarian Hyperstimulation Syndrome - metabolism | Vascular Endothelial Growth Factor A - metabolism | Reproductive Control Agents - therapeutic use | Chorionic Gonadotropin - therapeutic use | Luteal Phase | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Ovulation Induction - methods | Ovarian Hyperstimulation Syndrome - prevention & control | Adult | Female | Aspirin - therapeutic use | Aromatase Inhibitors - therapeutic use | Oocyte Retrieval - methods | Nitriles - therapeutic use | Triazoles - therapeutic use | Antimitotic agents | Chorionic gonadotropin | Endothelial growth factors | Glycoproteins | Permeability | Antineoplastic agents | Endothelium
Journal Article
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 10/2019, Volume 54, Issue S1, pp. 423 - 423
Journal Article
Ultrasound in Obstetrics & Gynecology, ISSN 0960-7692, 10/2019, Volume 54, Issue S1, pp. 434 - 434
Journal Article
Human Reproduction, ISSN 0268-1161, 9/2013, Volume 28, Issue 9, pp. 2511 - 2521
STUDY QUESTION Does a GnRH agonist (GnRHa) trigger followed by a bolus of 1.500 IU hCG in a group of patients at risk of ovarian hyperstimulation syndrome... 
IVF | ovarian hyperstimulation syndrome | GnRH agonist trigger | hCG | GnRH antagonist | OVULATION INDUCTION | LOW-DOSE HCG | HUMAN CHORIONIC-GONADOTROPIN | LUTEINIZING-HORMONE | OBSTETRICS & GYNECOLOGY | FINAL OOCYTE MATURATION | REPRODUCTIVE BIOLOGY | HYPERSTIMULATION SYNDROME | IN-VITRO FERTILIZATION | CORPUS-LUTEUM | ENDOTHELIAL GROWTH-FACTOR | AGONIST | Corpus Luteum - diagnostic imaging | Corpus Luteum - drug effects | Humans | Risk | Ovarian Hyperstimulation Syndrome - epidemiology | Recombinant Proteins - adverse effects | Chorionic Gonadotropin - pharmacology | Feasibility Studies | Incidence | Dose-Response Relationship, Drug | Fertility Agents, Female - pharmacology | Early Termination of Clinical Trials | Ovarian Hyperstimulation Syndrome - prevention & control | Ultrasonography | Adult | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - agonists | Ovulation Induction - adverse effects | Precision Medicine | Fertilization in Vitro - adverse effects | Severity of Illness Index | Follicle Stimulating Hormone, Human - pharmacology | Infertility, Female - diagnostic imaging | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Recombinant Proteins - pharmacology | Recombinant Proteins - administration & dosage | Chorionic Gonadotropin - administration & dosage | Chorionic Gonadotropin - adverse effects | Ovary - diagnostic imaging | Denmark - epidemiology | Fertility Agents, Female - adverse effects | Infertility, Female - therapy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2016, Volume 375, Issue 6, pp. 523 - 533
Journal Article
Human Reproduction, ISSN 0268-1161, 9/2013, Volume 28, Issue 9, pp. 2522 - 2528
STUDY QUESTION Is severe early ovarian hyperstimulation syndrome (OHSS) completely prevented with the GnRH agonist trigger and 1500 IU hCG luteal rescue... 
in vitro fertilization | ovarian hyperstimulation syndrome | hCG | GnRH agonist | GnRH antagonist | LOW-DOSE HCG | PREVENTION | COMBINATION | OBSTETRICS & GYNECOLOGY | FINAL OOCYTE MATURATION | REPRODUCTIVE BIOLOGY | RESCUE | CYCLES | OHSS | Estradiol - blood | Triptorelin Pamoate - pharmacology | Corpus Luteum - diagnostic imaging | Corpus Luteum - drug effects | Humans | Ovarian Hyperstimulation Syndrome - epidemiology | Chorionic Gonadotropin - pharmacology | Fertility Agents, Female - pharmacology | Ovarian Hyperstimulation Syndrome - prevention & control | Ultrasonography | Buserelin - pharmacology | Adult | Female | Ovary - drug effects | Retrospective Studies | Buserelin - adverse effects | Gonadotropin-Releasing Hormone - agonists | Ovulation Induction - adverse effects | Fertilization in Vitro - adverse effects | Severity of Illness Index | Quebec - epidemiology | Risk Factors | Infertility, Female - diagnostic imaging | Triptorelin Pamoate - adverse effects | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Infertility, Female - blood | Chorionic Gonadotropin - administration & dosage | Chorionic Gonadotropin - adverse effects | Turkey - epidemiology | Ovary - diagnostic imaging | Fertility Agents, Female - adverse effects | Cohort Studies | Infertility, Female - therapy | Ovarian Hyperstimulation Syndrome - physiopathology
Journal Article
Journal Article
A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY TO ASSESS THE EFFICACY OF KETOCONAZOLE FOR REDUCING THE RISK OF OVARIAN HYPERSTIMULATION SYNDROME, 12/2005
Background: In order to evaluate the role of ketoconazole in the prevention of ovarian hyperstimulation syndrome (OHSS) in women with polycystic ovary syndrome... 
Polycystic ovary syndrome, ovarian hyperstimulation syndrome, ketoconazole
Journal